Increased polyamine production is observed in a variety of chronic neuroinflammatory disorders, but in vitro and in vivo studies yield conflicting data on the immunomodulatory consequences of their production. Ornithine decarboxylase (ODC) is the rate-limiting enzyme in endogenous polyamine production. To identify the role of polyamine production in CNS-intrinsic inflammatory responses, we defined CNS sites of ODC expression and the consequences of inhibiting ODC in response to intracerebral injection of LPS ± IFNc. In situ hybridization analysis revealed that both neurons and non-neuronal cells rapidly respond to LPS ± IFNc by increasing ODC expression. Inhibiting ODC by co-injecting DFMO decreased LPS-induced CCL2 expression and macrophage influx into the CNS, without altering LPS-induced microglial or macrophage activation. Conversely, intracerebral injection of polyamines was sufficient to trigger macrophage influx into the CNS of wild-type but not CCL2KO mice, demonstrating the dependence of macrophage influx on CNS expression of CCL2. Consistent with these data, addition of putrescine and spermine to mixed glial cultures dramatically increased CCL2 expression and to a much lesser extent, TNF expression. Addition of all three polyamines to mixed glial cultures also decreased the numbers and percentages of oligodendrocytes present. However, in vivo, inhibiting the basal levels of polyamine production was sufficient to induce expression of apolipoprotein D, a marker of oxidative stress, within white matter tracts. Considered together, our data indicate that: (1) CNS-resident cells including neurons play active roles in recruiting pro-inflammatory TREM1-positive macrophages into the CNS via polyamine-dependent induction of CCL2 expression and (2) modulating polyamine production in vivo may be a difficult strategy to limit inflammation and promote repair due to the dual homeostatic and proinflammatory roles played by polyamines.
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Introduction
Putrescine, spermidine and spermine belong to a class of small polycationic molecules termed polyamines (Bistulfi et al., 2009; Moinard et al., 2005; Pegg, 2009; Zhang et al., 2000) . In healthy mature brain tissue, polyamine levels are relatively low (nanomolar levels). However, polyamine levels can reach micromolar and even millimolar levels during active inflammatory responses as well as during periods with active cell proliferation such as during CNS development (Bistulfi et al., 2009; Moinard et al., 2005; Pegg, 2009; Slotkin and Bartolome, 1986; Thomas and Thomas, 2001; Zhang et al., 2000) . Ornithine decarboxylase (ODC) is the rate-limiting enzyme in the synthesis of all three polyamines in vivo, catalyzing the conversion of ornithine to putrescine (Fig. 1A) (Bistulfi et al., 2009; Moinard et al., 2005; Pegg, 2009) . Increased CNS levels of ODC and polyamines are detected in several animal models of neurodegenerative disorders including amyotrophic lateral sclerosis, ischemia and Alzheimer's disease as well as in brain tissue from individuals with Alzheimer's disease (Clarkson et al., 2004; Kim et al., 2009; Morrison and Kish, 1995; Morrison et al., 1998; Virgili et al., 2006) . Functionally, polyamines are best characterized for 0889-1591/$ -see front matter Ó 2010 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2010.12.016
Abbreviations: ApoD, apolipoprotein D; AMPA, a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate; CNP, 2 0 ,3 0 -cyclic nucleotide 3 0 -phophodiesterase; CNS, central nervous system; Ct, comparative cycle threshold; DMEM, Dubecco's modified Eagle's medium; DFMO, a-di-fluoro-methyl-ornithine; FBS, fetal bovine serum; HPRT, hypoxanthine phosphoribosyl transferase; IL, interleukin; INOS, inducible nitric oxide synthase; LPS, lipopolysaccharide; MG, microglia; MP, macrophage; NMDA, N-methyl-D-aspartic acid; ODC, ornithine decarboxylase; PE, phycoerythrin; qPCR, quantitative real-time PCR; SPF, specific pathogen free; SSAT, spermine-spermidine N1-acetyl transferase; TLR, toll-like receptor; TNF, tumor necrosis factor; TREM, triggering receptor expressed on myeloid cells.
